Options Update: Human Genome November volatility at 248 into data

Full story: Blogging Stocks

Human Genome closed at $19.97. HGSI's Benlysta, a lupus treatment, is expected to have phase 3 data released on November 2. HGSI November option implied volatility is at 249, December is at 170, January is at 143 and April is at 112, according to Track Data, suggesting large movement.

Read Comments

Comments

Showing posts 1 - 1 of1

Charlo

Vancouver, Canada

Research on new Benlysta lupus drug has been completed: http://www.orderonlinedrugs.com/drug-news/200...

	Sign up to receive email when someone responds
	(registration is not required)

Showing posts 1 - 1 of1

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Lupus Discussions

Topic	Updated	Last By	Comments
CellCept (mycophenolate mofetil): Quarter of p... (Mar '06)	Dec 19	MPA	111
Lupus Support Group (Nov '06)	Nov '09	Ana	15
Beauty queen fights lupus (20090108) (Jan '09)	Nov '09	Ana	4
Is it lupus or what? (Feb '09)	Oct '09	Laura	9
Methotrexate and Fevers?	Oct '09	Laura	1
Looking for support. (May '09)	Oct '09	Laura	11
help ! (Nov '08)	Oct '09	Laura	2